Disc Medicine, Inc.IRON

$70.79+0.58 (+0.83%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$3B
Mid-cap
+1631%
2020 — today
10-Year Price
-30%
2020 — today
52-Week Range
$51.13$94.11
Current $70.79· 46%

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Valuation in context

P/E ratio
-10.7
N/A
Not meaningful — company is unprofitable
P/B ratio
4.0
Historically pricey
Historically pricey — last 10 years
FCF Yield
-7.4%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when IRON is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.